Astrana Health CEO withholds 7.2K shares for tax
Astrana Health’s CEO surrendered shares to cover RSU tax withholding while retaining a substantial direct and trust-related equity position.
Rhea-AI Filing Summary
Astrana Health, Inc. (ASTH) reported that CEO and President Brandon Sim surrendered 7,163 shares of common stock on September 5, 2026 to pay tax withholding obligations associated with vested restricted stock units, at a reported price of $38.47 per share. This tax-withholding disposition did not involve an open-market sale and no Rule 10b5-1 trading plan is reported. Following the transaction, he holds 1,238,861 shares directly, including unvested restricted stock and restricted stock units scheduled to vest over multiple semi-annual installments, and also has indirect interests in shares held by two irrevocable trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F3, F4, F5 | 7,163 | $38.47 | $276K |
| holding | Common Stock F1 | -- | -- | -- |
| holding | Common Stock F2 | -- | -- | -- |
Footnotes (5)
- F1. These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F2. These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F3. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026.
- F4. Includes 34,207 shares of unvested restricted stock, which will vest in two equal semi-annual installments, beginning September 30, 2026, subject to continuous employment with the Issuer. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 91,027 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026.
- F5. Includes 2,152 shares acquired under the Issuer's Employee Stock Purchase Plan.
Key Figures
Key Terms
restricted stock units financial
unvested restricted stock financial
Employee Stock Purchase Plan financial
pecuniary interest financial
beneficial ownership financial
FAQ
What transaction did ASTH CEO Brandon Sim report on September 5, 2026?
Was the ASTH CEO’s September 5, 2026 Form 4 transaction an open-market sale?
What indirect Astrana Health (ASTH) holdings are reported for Brandon Sim?
Are any of the ASTH CEO’s future equity awards subject to vesting conditions?
AI-generated analysis. How Rhea-AI works. Not financial advice.